Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Income towards Parent Company (2015 - 2026)

Medpace Holdings' (MEDP) quarterly Income towards Parent Company came in at $121.4 million in Q2 2026, up 34.46% on a YoY basis from $90.3 million in Q2 2025, and down 2.02% quarter-over-quarter from $123.9 million in Q1 2026.

Analysis

Medpace Holdings (MEDP) Income towards Parent Company (2015 - 2026) Analysis & Trends

Medpace Holdings (MEDP) has reported Income towards Parent Company for 12 consecutive years, with $121.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Income towards Parent Company rose 34.46% year-over-year to $121.4 million; the trailing twelve-month figure through Jun 2026 stood at $491.5 million (up 17.5% YoY), and the FY2025 full-year result was $451.1 million, up 11.56% from the prior year.
  • Income towards Parent Company retreated to $121.4 million in Q2 2026 per MEDP's latest filing, from $123.9 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $135.1 million in Q4 2025 and bottomed at $49.4 million in Q2 2022.
  • Historically, Income towards Parent Company has averaged $90.5 million across 5 years, with a median of $89.3 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Income towards Parent Company soared 49.45% in 2024, then gained 2.16% in 2025.
  • Over 5 years, Income towards Parent Company stood at $68.7 million in 2022, then increased by 14.02% to $78.3 million in 2023, then jumped by 49.45% to $117.0 million in 2024, then gained by 15.48% to $135.1 million in 2025, then decreased by 10.19% to $121.4 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered $121.4 million, $123.9 million, and $135.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 121.36 Mn
Mar 31, 2026 123.87 Mn
Dec 31, 2025 135.13 Mn
Sep 30, 2025 111.14 Mn
Jun 30, 2025 90.26 Mn
Mar 31, 2025 114.60 Mn
Dec 31, 2024 117.02 Mn
Sep 30, 2024 96.43 Mn
Jun 30, 2024 88.35 Mn
Mar 31, 2024 102.59 Mn
Dec 31, 2023 78.30 Mn
Sep 30, 2023 70.55 Mn
Jun 30, 2023 61.07 Mn
Mar 31, 2023 72.89 Mn
Dec 31, 2022 68.67 Mn
Sep 30, 2022 66.03 Mn
Jun 30, 2022 49.36 Mn
Mar 31, 2022 61.31 Mn
Dec 31, 2021 50.03 Mn
Sep 30, 2021 48.57 Mn